Sexual network distribution of HIV self-testing kits: Findings from the process evaluation of an intervention for men who have sex with men in China.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 30 07 2019
accepted: 07 04 2020
entrez: 23 4 2020
pubmed: 23 4 2020
medline: 29 7 2020
Statut: epublish

Résumé

The World Health Organization has recommended HIV self-testing (HIVST) as an alternative testing strategy given the limitations of facility-based testing. While the benefits of HIV self-testing have been demonstrated at the individual level among men who have sex with men (MSM), limited data exist on if this testing approach can be effectively diffused through individuals' social or sexual networks. The objectives of this study were to examine patterns and correlates of HIVST distribution within Chinese MSM's sexual networks. Data used for this analysis was a part of the process evaluation of an HIVST intervention trial among MSM in Nanjing, China. Between May and October 2017, we enrolled 400 men into the trial. Participants assigned to the intervention group (N = 200) were given three HIVST kits at baseline and could request more during the follow-up periods. We incorporated measures for process evaluation in the self-administered online follow-up surveys. This analysis reported findings from the three-month follow-up survey in the intervention group. Frequencies and percentages were used to describe characteristics of participants who distributed kits to their sexual partners as well as patterns of distribution. Multivariable logistic regression was conducted to identify independent correlates of participants who distributed the kits. Of the 177 participants retained (88.5%) at the three-month follow-up, 72 (40.7%) distributed one or more kits to either primary or casual partners. About half of distributors (51.4%) gave one HIVST kit to their sexual partners while 15.3% distributed 3 or more. Over half gave these kits (58.3%) to primary sexual partners while 27.8% reported giving the kits to both primary and casual partners. About half (54.2%) of distributors used the kits together with their partners. Compared to participants who had an HIV test in the past six months, those who tested over six months ago or never tested had significantly lower odds of distributing the kits (AOR = 0.484, 95% CI: 0.250-0.983, p = 0.032). Compared to those who had not used the kits themselves, participants who did had significantly higher odds of distributing the kits (AOR = 3.345, 95% CI: 1.488-7.517, p = 0.003). Participants who reported higher HIV testing efficacy had 2.051 fold greater odds (95% CI: 1.062-3.961, p = 0.033) of distributing the kits compared to those who had lower efficacy. Our study demonstrated that a sexual network-based approach to distributing HIVST among Chinese MSM is feasible and can be a promising strategy to improve the effectiveness of HIVST programs including its reach to untested men. Such approach should be complimented by intervention components that enhance HIV testing efficacy and improve experiences of HIVST.

Sections du résumé

BACKGROUND
The World Health Organization has recommended HIV self-testing (HIVST) as an alternative testing strategy given the limitations of facility-based testing. While the benefits of HIV self-testing have been demonstrated at the individual level among men who have sex with men (MSM), limited data exist on if this testing approach can be effectively diffused through individuals' social or sexual networks. The objectives of this study were to examine patterns and correlates of HIVST distribution within Chinese MSM's sexual networks.
METHODS
Data used for this analysis was a part of the process evaluation of an HIVST intervention trial among MSM in Nanjing, China. Between May and October 2017, we enrolled 400 men into the trial. Participants assigned to the intervention group (N = 200) were given three HIVST kits at baseline and could request more during the follow-up periods. We incorporated measures for process evaluation in the self-administered online follow-up surveys. This analysis reported findings from the three-month follow-up survey in the intervention group. Frequencies and percentages were used to describe characteristics of participants who distributed kits to their sexual partners as well as patterns of distribution. Multivariable logistic regression was conducted to identify independent correlates of participants who distributed the kits.
RESULTS
Of the 177 participants retained (88.5%) at the three-month follow-up, 72 (40.7%) distributed one or more kits to either primary or casual partners. About half of distributors (51.4%) gave one HIVST kit to their sexual partners while 15.3% distributed 3 or more. Over half gave these kits (58.3%) to primary sexual partners while 27.8% reported giving the kits to both primary and casual partners. About half (54.2%) of distributors used the kits together with their partners. Compared to participants who had an HIV test in the past six months, those who tested over six months ago or never tested had significantly lower odds of distributing the kits (AOR = 0.484, 95% CI: 0.250-0.983, p = 0.032). Compared to those who had not used the kits themselves, participants who did had significantly higher odds of distributing the kits (AOR = 3.345, 95% CI: 1.488-7.517, p = 0.003). Participants who reported higher HIV testing efficacy had 2.051 fold greater odds (95% CI: 1.062-3.961, p = 0.033) of distributing the kits compared to those who had lower efficacy.
CONCLUSION
Our study demonstrated that a sexual network-based approach to distributing HIVST among Chinese MSM is feasible and can be a promising strategy to improve the effectiveness of HIVST programs including its reach to untested men. Such approach should be complimented by intervention components that enhance HIV testing efficacy and improve experiences of HIVST.

Identifiants

pubmed: 32320457
doi: 10.1371/journal.pone.0232094
pii: PONE-D-19-21448
pmc: PMC7176132
doi:

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0232094

Subventions

Organisme : NIMH NIH HHS
ID : R21 MH118945
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH109359
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet HIV. 2018 Jun;5(6):e277-e290
pubmed: 29703707
BMJ Open. 2019 Jan 30;9(1):e021955
pubmed: 30705234
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):38-45
pubmed: 29771792
Public Health. 2011 May;125(5):275-82
pubmed: 21419466
Biomed Environ Sci. 2017 Jun;30(6):407-417
pubmed: 28705264
AIDS Behav. 2013 Oct;17(8):2732-41
pubmed: 23420102
PLoS One. 2014 Jul 22;9(7):e102812
pubmed: 25051160
PLoS Med. 2018 Aug 28;15(8):e1002645
pubmed: 30153265
AIDS Behav. 2015 Nov;19(11):1949-65
pubmed: 26054390
PLoS Med. 2015 Sep 08;12(9):e1001873
pubmed: 26348035
Lancet HIV. 2017 Jun;4(6):e241-e250
pubmed: 28219619
PLoS One. 2018 Nov 8;13(11):e0206849
pubmed: 30408055
J Acquir Immune Defic Syndr. 2018 Mar 1;77(3):279-287
pubmed: 29210826
AIDS Behav. 2012 Oct;16(7):1717-28
pubmed: 22677975
Sex Transm Dis. 2018 Dec;45(12):818-822
pubmed: 29944646
BMC Public Health. 2013 Aug 08;13:735
pubmed: 23924387
PLoS Med. 2007 Dec;4(12):e339
pubmed: 18052602
PLoS One. 2018 Aug 9;13(8):e0201953
pubmed: 30092072
PLoS Med. 2013;10(4):e1001414
pubmed: 23565066
BMC Public Health. 2016 Nov 10;16(1):1152
pubmed: 27832761
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Jun 10;39(6):707-709
pubmed: 29936732
Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Nov 6;51(11):966-970
pubmed: 29136739
AIDS Behav. 2018 Aug;22(8):2387-2412
pubmed: 29550941
Lancet Infect Dis. 2013 Nov;13(11):955-63
pubmed: 24107261
PLoS One. 2016 Apr 25;11(4):e0154466
pubmed: 27111540
AIDS Behav. 2016 Apr;20(4):928-38
pubmed: 26511864

Auteurs

Wenjing Xiao (W)

Nanjing Medical University, Nanjing, Jiangsu, China.

Li Yan (L)

Xuzhou Central Hospital, Xuzhou, Jiangsu, China.

Liping Chen (L)

Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.

Gengfeng Fu (G)

Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.

Haitao Yang (H)

Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China.

Cui Yang (C)

Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Hongjing Yan (H)

Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.

Chongyi Wei (C)

Department of Health Behavior, Society, and Policy, Rutgers School of Public Health, New Jersey, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH